Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001232524-25-000063
Filing Date
2025-08-06
Accepted
2025-08-06 07:33:51
Documents
91
Period of Report
2025-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q jazz-20250630.htm   iXBRL 10-Q 1736498
2 LICENSE AND OPTION AGREEMENT jazzq22025ex101a.htm EX-10.1A 792771
3 AMENDED AND RESTATED LICENSE AND OPTION AGREEMENT jazzq22025ex101b.htm EX-10.1B 740030
4 LETTER AGREEMENT jazzq22025ex102.htm EX-10.2 64137
5 CERTIFICATION OF CEO PURSUANT TO RULES 13A-14(A) AND 15D-14(A) jazzq22025ex311.htm EX-31.1 10116
6 CERTIFICATION OF CFO PURSUANT TO RULES 13A-14(A) AND 15D-14(A) jazzq22025ex312.htm EX-31.2 10186
7 CERTIFICATIONS OF CEO AND CFO PURSUANT TO 18 U.S.C. SECTION 1350 jazzq22025ex321.htm EX-32.1 6916
13 GRAPHIC image_81.jpg GRAPHIC 4269
14 GRAPHIC image_82a.jpg GRAPHIC 4701
  Complete submission text file 0001232524-25-000063.txt   10634290

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT jazz-20250630.xsd EX-101.SCH 57598
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT jazz-20250630_cal.xml EX-101.CAL 107217
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT jazz-20250630_def.xml EX-101.DEF 278009
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT jazz-20250630_lab.xml EX-101.LAB 703831
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT jazz-20250630_pre.xml EX-101.PRE 496119
94 EXTRACTED XBRL INSTANCE DOCUMENT jazz-20250630_htm.xml XML 1347959
Mailing Address FIFTH FLOOR, WATERLOO EXCHANGE WATERLOO ROAD DUBLIN Ireland D04 E5W7
Business Address FIFTH FLOOR, WATERLOO EXCHANGE WATERLOO ROAD DUBLIN Ireland D04 E5W7 353-1-634-7800
Jazz Pharmaceuticals plc (Filer) CIK: 0001232524 (see all company filings)

EIN.: 981032470 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33500 | Film No.: 251187469
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)